文献速递颅颌面外科创面修复

罕见颅面裂患者眼部病变与视力结局:102例当代队列研究

Ocular Morbidity and Visual Outcomes in Rare Craniofacial Clefts: A Contemporary Cohort Study of 102 Cases.
PubMed 文献 · Plast Reconstr Surg · 2026-01-21

该回顾性队列研究纳入102例罕见颅面裂患儿,平均就诊年龄2.0±3.8岁,随访9.6±7.5年,评估眶周病变、手术负担及视力结局。80.4%存在眶周异常,38.2%视力差;视力差与裂数量更多相关,下眶周裂、下内侧裂及眼球异常为独立预测因素,挑战了上裂威胁最大的传统假设。

要点

  • 罕见颅面裂患儿中80.4%存在眶周异常,38.2%视力差。
  • 下眶周裂、下内侧裂及眼球异常是视力差的独立预测因素。
  • 上眶周裂与眼表病变相关,但校正混杂后不预测视力差。

核心结论

  • 超过三分之一的罕见颅面裂患者存在视力丧失。
  • 下裂而非传统认为的上裂携带不成比例的高视力损害风险。
  • 需早期、裂型特异性眼科评估及多学科协作以预防不可逆视力丧失。

研究设计与样本

  • 回顾性队列研究,纳入102例罕见颅面裂患儿。
  • 裂型分为上眶周(Tessier 9-11)、下眶周(3-6,8)、上内侧(12-14)、下内侧(0-2)及外侧(7)。
  • 平均就诊年龄2.0±3.8岁,随访9.6±7.5年。

主要发现

  • 39例(38.2%)视力差,与裂数量更多相关(2.3 vs 1.6,p=0.002)。
  • 下眶周裂(p=0.004)、下内侧裂(p=0.023)及眼球异常(p<0.020)为视力差的独立预测因素。

临床怎么用

  • 对罕见颅面裂患者应早期行裂型特异性眼科评估。
  • 下眶周裂和下内侧裂患者需重点筛查视力损害。
  • 需采取即刻保护措施以预防不可逆视力丧失并指导重建规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Craniofacial clefts are rare congenital anomalies with heterogeneous presentations and significant functional and reconstructive challenges. This study evaluates periorbital pathology, surgical burden, and visual outcomes to inform care strategies for affected patients. METHODS: A retrospective cohort study was conducted of patients with rare craniofacial clefts. Clefts were categorized into superior periorbital (Tessier 9-11), inferior periorbital (3-6, 8), superior medial (12-14), inferior medial (0-2), and lateral (7). RESULTS: Among 102 children, mean age at presentation was 2.0±3.8 years with follow-up 9.6±7.5 years. Thirteen (12.7%) had superior periorbital, 32 (31.4%) had inferior periorbital, 22 (21.6%) had superior medial, 35 (34.3%) had inferior medial, and 44 (43.1%) had lateral clefts. Eighty-two (80.4%) had periorbital abnormalities, including surface pathology (n=41, 40.2%), strabismus (n=26, 25.5%), and nasolacrimal duct obstruction (n=25, 23.5%). Sixty-four (63.3%) subjects underwent 484 periorbital procedures. Poor vision was observed in 39 patients (38.2%) and was associated with a higher number of clefts (2.3 vs 1.6, p=0.002). Inferior periorbital (p=0.004), inferior medial (p=0.023), and globe anomalies (p<0.020), were independent predictors of poor vision. Superior periorbital clefts were associated with ocular surface pathology (p=0.016) but not poor vision after adjusting for confounders. CONCLUSIONS: Over one-third of patients with rare craniofacial clefts experience vision loss. Contrary to traditional assumptions that superior clefts pose the greatest threat to vision, inferior clefts carry a disproportionately high risk of visual impairment. These findings underscore the need for early, cleft-specific ophthalmologic evaluation, coordinated multidisciplinary care, and immediate protective measures to prevent irreversible vision loss and guide reconstructive planning.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hu AC, Ng JJ, Zhong A, et al. Ocular Morbidity and Visual Outcomes in Rare Craniofacial Clefts: A Contemporary Cohort Study of 102 Cases. Plast Reconstr Surg. 2026. PMID: 41564001. doi:10.1097/PRS.0000000000012828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。